Abstract
Prolonged exposure to estrogens as hormone replacement therapy agents to relieve menopausal symptoms is linked to an increased risk of breast and other types of human cancers. Previous studies showed the carcinogenic effect of estrogens occurred through formation of carcinogenic/tumor initiating quinone metabolites. Hence, it was found that occupying both ortho-positions by substituents on the A-ring effectively prevent the quinone formation. Hence, a new substituted phenolic series of A-CD estrogen family, where the five-membered Dring is substituted with a six-membered one, was designed and synthesized. Desired compounds were prepared by stereospecific reduction of Wieland-Miescher ketone followed by coupling with lithiated protected phenols. Dehydration of corresponding alcohols afforded the alkene intermediates. Final hydrogenation removed the protecting group and selectively reduced the double bond to give the desired 9-(S)-isomer.
Keywords: 17β-Estradiol, A-CD analogs, non-quinone forming ligands, stereoselectivity, wieland-miescher ketone, carcinogenicity.
Current Organic Chemistry
Title:Synthesis of New A-CD Estrogenic Compounds: D-Homo-analogs Lacking B-ring
Volume: 20 Issue: 25
Author(s): Armin Dadgar, Abbas Shafiee and Latifeh Navidpour
Affiliation:
Keywords: 17β-Estradiol, A-CD analogs, non-quinone forming ligands, stereoselectivity, wieland-miescher ketone, carcinogenicity.
Abstract: Prolonged exposure to estrogens as hormone replacement therapy agents to relieve menopausal symptoms is linked to an increased risk of breast and other types of human cancers. Previous studies showed the carcinogenic effect of estrogens occurred through formation of carcinogenic/tumor initiating quinone metabolites. Hence, it was found that occupying both ortho-positions by substituents on the A-ring effectively prevent the quinone formation. Hence, a new substituted phenolic series of A-CD estrogen family, where the five-membered Dring is substituted with a six-membered one, was designed and synthesized. Desired compounds were prepared by stereospecific reduction of Wieland-Miescher ketone followed by coupling with lithiated protected phenols. Dehydration of corresponding alcohols afforded the alkene intermediates. Final hydrogenation removed the protecting group and selectively reduced the double bond to give the desired 9-(S)-isomer.
Export Options
About this article
Cite this article as:
Dadgar Armin, Shafiee Abbas and Navidpour Latifeh, Synthesis of New A-CD Estrogenic Compounds: D-Homo-analogs Lacking B-ring, Current Organic Chemistry 2016; 20 (25) . https://dx.doi.org/10.2174/1385272820666160525142520
DOI https://dx.doi.org/10.2174/1385272820666160525142520 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Electrochemical C-X bond formation
Conventional methods for carrying out carbon–X bond formation are typically conducted at harsh reaction conditions, and rely on expensive catalysts as well as the use of stoichiometric, and perhaps toxic, oxidants. In this regard, electrochemical synthesis has recently been recognized as a sustainable and scalable strategy for the construction of ...read more
From Lab Bench to Algorithm: The Future of Organic Chemistry Powered by AI
Organic chemistry, with its intricate dance of molecules and reactions, is undergoing a transformation fuelled by the power of Artificial Intelligence (AI) and Machine Learning (ML). The integration of AI/ML with Organic Chemistry is revolutionizing the field by enhancing the efficiency and accuracy of chemical research and development. These technologies ...read more
N-Heterocyclics: Synthesis, Computational Studies, and Coordination Chemistry - A synthetic perspective
N-heterocycles, such as phenanthroline, quinoline, or their organometallic complexes, are widely used in a variety of fields, including chemistry, biochemistry, and coordination chemistry. They play a key role in many chemical and biological processes as biological ligands, medicinal agents, catalysts in organic synthesis, molecular probes and sensors, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
RAAS Inhibition and Renal Protection
Current Pharmaceutical Design Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design The Crosstalk Between miRNA and Mammalian Circadian Clock
Current Medicinal Chemistry Inflammatory Cytokines and Atherosclerosis Possible Application for the Gene Therapy
Vascular Disease Prevention (Discontinued) Effect of Dietary Education on Cardiovascular Risk Factors in Rheumatoid Arthritis Patients
Current Rheumatology Reviews SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Inflammation in Atherosclerosis: Current Therapeutic Approaches (Executive Guest Editor: Dimitris Tousoulis)]
Current Pharmaceutical Design Structure and Function of Small Non-Peptide CRF Antagonists and their Potential Clinical Use
Current Molecular Pharmacology P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease
Current Medicinal Chemistry Prediction and Dissection of Protein-RNA Interactions by Molecular Descriptors
Current Topics in Medicinal Chemistry Novel Quercetin Glycosides as Potent Anti-MRSA and Anti-VRE Agents
Recent Patents on Anti-Infective Drug Discovery Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension
Current Vascular Pharmacology Cerebrospinal Fluid Proteins in the Diagnosis of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Pharmacotherapy for Intermittent Claudication: From Consensus-Based to Evidence-Based Treatment
Vascular Disease Prevention (Discontinued) New Approaches for the Treatment of Chagas Disease
Current Drug Targets Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design Insulin Therapy for Improving Cardiac Surgical Outcomes
Current Drug Targets